Arkin Bio Ventures Gpgp Ltd. - Net Worth and Insider Trading

Arkin Bio Ventures Gpgp Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Arkin Bio Ventures Gpgp Ltd. owns 1 companies in total, including Werewolf Therapeutics Inc (HOWL) .

Click here to see the complete history of Arkin Bio Ventures Gpgp Ltd.’s form 4 insider trades.

Insider Ownership Summary of Arkin Bio Ventures Gpgp Ltd.

Ticker	Company	Transaction Date	Type of Owner
HOWL	Werewolf Therapeutics Inc	2021-04-29	10 percent owner

Arkin Bio Ventures Gpgp Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Arkin Bio Ventures Gpgp Ltd. Ownership Network

Ownership Network List of Arkin Bio Ventures Gpgp Ltd.

No Data

Ownership Network Relation of Arkin Bio Ventures Gpgp Ltd.

Arkin Bio Ventures Gpgp Ltd. Owned Company Details

What does Werewolf Therapeutics Inc do?

Who are the key executives at Werewolf Therapeutics Inc?

Arkin Bio Ventures Gpgp Ltd. is the 10 percent owner of Werewolf Therapeutics Inc. Other key executives at Werewolf Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , 10 percent owner Mpm Bioventures 2014, L.p. , and 10 percent owner Mpm Oncology Innovations Fund Lp .

Werewolf Therapeutics Inc (HOWL) Insider Trades Summary

Over the past 18 months, Arkin Bio Ventures Gpgp Ltd. made no insider transaction in Werewolf Therapeutics Inc (HOWL). Other recent insider transactions involving Werewolf Therapeutics Inc (HOWL) include a net purchase of 536,426 shares made by Ra Capital Healthcare Fund Lp , a net sale of 4,386 shares made by Mpm Oncology Innovations Fund Lp , and a net sale of 2,425 shares made by Luke Evnin .

In summary, during the past 3 months, insiders sold 8,774 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 536,426 shares, with a net purchase of 527,652 shares. During the past 18 months, 8,774 shares of Werewolf Therapeutics Inc (HOWL) were sold and 536,426 shares were bought by its insiders, resulting in a net purchase of 527,652 shares.

Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Werewolf Therapeutics Inc Insider Transactions

No Available Data

Arkin Bio Ventures Gpgp Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Arkin Bio Ventures Gpgp Ltd.. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Arkin Bio Ventures Gpgp Ltd.'s mailing address is: Herzliya L3 4672406.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.